The 2nd Kyoto Symposium on the Future of Pharmaceuticals was held at Kyoto University on October 30, 2010. Over 100 researchers and students listened to presentations by FIRST researchers from Shimadzu and Kyoto University. The symposium was intended to introduce the summary of the FIRST research program and its objective to develop the next-generation mass spectrometer through industry-university cooperation, and contribute to drug discovery and new diagnostic methods. A lively discussion followed each presentation by a researcher.
|
Presentation Materials (Digest Version, Japanese)
|
|
| 13:40-14:00 | Introduction to World-Leading Drug Discovery Research Center （2,274KB） Gozoh Tsujimoto, Director, World-Leading Drug Discovery Research Center |
| 14:00-14:30 | Development of New Antipruritic Drug Nalfurafine and Its Significance （2,325KB） Jun Utsumi, Prof., World-Leading Drug Discovery Research Center |
| 14:30-15:00 | Current Status and Future Outlook on Diagnosis and Treatment of Alzheimer’s Disease （4,407KB） Hachiro Sugimoto, Visiting Prof., World-Leading Drug Discovery Research Center |
| 15:20-15:50 | Development of a Next-Generation Mass Spectrometer and Its Contribution to Drug Discovery and Diagnostics （559KB） Koichi Tanaka, General Manager, Koichi Tanaka Laboratory of Advanced Science and Technology, Shimadzu Corp. |
| 15:50-16:20 | Deployment of Diagnostic and Drug Discovery Methods and in FIRST Research Program （1,593KB） Taka-Aki Sato, Director, Shimadzu Life Science Research Center / Corporate Strategy Planning Department |
| Symposium Agenda（332KB） | |
